UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peer-Led Team Learning Helps Minority Students Succeed

PLoS biology, 2016-03, Vol.14 (3), p.e1002398-e1002398

2016

Volltextzugriff (PDF)

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Journal of clinical oncology, 2014-06, Vol.32 (18), p.1927-1934

2014

Volltextzugriff (PDF)

A Phase II Study of Epirubicin and Thalidomide in Unresectable or Metastatic Hepatocellular Carcinoma

The oncologist (Dayton, Ohio), 2005-06, Vol.10 (6), p.392-398

2005

Volltextzugriff (PDF)

Protein–protein interactions in human disease

Current opinion in structural biology, 2005-08, Vol.15 (4), p.441-446

2005

Volltextzugriff (PDF)

Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors

Journal of clinical oncology, 2006-01, Vol.24 (3), p.401-406

2006

Volltextzugriff (PDF)

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1898-1903

2006

Volltextzugriff (PDF)

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Nature medicine, 2004-02, Vol.10 (2), p.145-147

2004

Volltextzugriff (PDF)

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

British journal of cancer, 2014-07, Vol.111 (3), p.430-436

2014

Volltextzugriff (PDF)

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

Journal of clinical oncology, 2005-11, Vol.23 (31), p.8136-8139

2005

Volltextzugriff (PDF)

Locally Advanced Pancreatic Cancer

Journal of clinical oncology, 2005-07, Vol.23 (20), p.4538-4544

2005

Volltextzugriff (PDF)

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1480-1490

2004

Volltextzugriff (PDF)

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5484-5492

2005

Volltextzugriff (PDF)

Phase I/II Study of Preoperative Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Cancer and Leukemia Group B 89901

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2557-2562

2006

Volltextzugriff (PDF)

Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer

Clinical cancer research, 2005-09, Vol.11 (18), p.6650-6656

2005

Volltextzugriff (PDF)

Unexpected Association between Induction of Immunity to the Universal Tumor Antigen CYP1B1 and Response to Next Therapy

Clinical cancer research, 2005-06, Vol.11 (12), p.4430-4436

2005

Volltextzugriff (PDF)

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer

Annals of oncology, 2007-07, Vol.18 (7), p.1185-1189

2007

Volltextzugriff (PDF)

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3772-3784

2002

Volltextzugriff (PDF)

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2014-09, Vol.14 (5), p.398-402

2014

Volltextzugriff (PDF)

Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1892-1897

2006

Volltextzugriff (PDF)

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6107-6116

2005

Volltextzugriff (PDF)

Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer

Annals of surgery, 2005-02, Vol.241 (2), p.295-299

2005

Volltextzugriff (PDF)

Disc stimulation and patterns of referred pain

Spine (Philadelphia, Pa. 1976), 2002-12, Vol.27 (24), p.2776-2781

2002

Volltextzugriff (PDF)

Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas

Clinical cancer research, 2004-09, Vol.10 (17), p.5732-5740

2004

Volltextzugriff (PDF)

Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex

The EMBO journal, 2004-09, Vol.23 (18), p.3589-3598

2004

Volltextzugriff (PDF)

The ability of pressure-controlled discography to predict surgical and nonsurgical outcomes

Spine (Philadelphia, Pa. 1976), 1999-02, Vol.24 (4), p.364-371

1999

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Englisch
(312)

Erscheinungsjahr

n.n

Thema

Science & Technology
(295)
Life Sciences & Biomedicine
(237)
Humans
(157)
Biological And Medical Sciences
(122)
Male
(118)
Female
(117)
Medical Sciences
(105)
Middle Aged
(81)
Animals
(66)
Adult
(64)
Aged
(60)
Physical Sciences
(49)
Cardiovascular System & Cardiology
(45)
Cardiac & Cardiovascular Systems
(42)
Oncology
(39)
Surgery
(34)
Treatment Outcome
(29)
Pharmacology. Drug Treatments
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Fundamental And Applied Biological Sciences. Psychology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peer-Led Team Learning Helps Minority Students Succeed

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

A Phase II Study of Epirubicin and Thalidomide in Unresectable or Metastatic Hepatocellular Carcinoma

Protein–protein interactions in human disease

Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

Locally Advanced Pancreatic Cancer

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Phase I/II Study of Preoperative Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Cancer and Leukemia Group B 89901

Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer

Unexpected Association between Induction of Immunity to the Universal Tumor Antigen CYP1B1 and Response to Next Therapy

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer

Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression

Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer

Disc stimulation and patterns of referred pain

Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas

Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex

The ability of pressure-controlled discography to predict surgical and nonsurgical outcomes

Suchergebnisse filtern